Evidence map›Paper›PMID 38633262›Full record

ArticleFrontiers in immunology2024

Immune system-related plasma extracellular vesicles in healthy aging.

Xin Zhang, Sisi Ma, Janet L Huebner, Syeda Iffat Naz, Noor Alnemer, Erik J Soderblom, Constantin Aliferis, Virginia Byers Kraus

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. CSPG4Osteoarthritis and cartilage open · 2026
    Article
  5. RYR1Journal of translational medicine · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xin ZhangDuke Molecular Physiology Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Sisi MaInstitute for Health Informatics, University of Minnesota School of Medicine, Minneapolis, MN, United States.
Janet L HuebnerDuke Molecular Physiology Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Syeda Iffat NazInstitute for Health Informatics, University of Minnesota School of Medicine, Minneapolis, MN, United States.
Noor AlnemerDuke Molecular Physiology Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Erik J SoderblomDuke Proteomics and Metabolomics Core Facility, Duke University School of Medicine, Duke University, Durham, NC, United States.
Constantin AliferisInstitute for Health Informatics, University of Minnesota School of Medicine, Minneapolis, MN, United States.
Virginia Byers KrausDuke Molecular Physiology Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.
Duke University · USUniversity of Minnesota · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI CATHLEEN S COLON-EMERIC, Susan Nicole Hastings · 2006 to 2026
$24.6M
Extracellular Vesicle Analyses to Develop Aging and Resilience BiomarkersR01AG070146 · NIA · DUKE UNIVERSITY · PI KRAUS, VIRGINIA B · 2021 to 2025
$3.1M
Extracellular Vesicles and Their Role in Hallmarks of AgingR56AG060895 · NIA · DUKE UNIVERSITY · PI KRAUS, VIRGINIA · 2018 to 2018
$659k
NCATS NIH HHS UM1 TR004405NIA NIH HHS P30 AG028716NIA NIH HHS R01 AG070146NIA NIH HHS R56 AG060895
6 · The paper itself

Abstract

Objectives: To identify age-related plasma extracellular vehicle (EVs) phenotypes in healthy adults. Methods: EV proteomics by high-resolution mass spectrometry to evaluate EV protein stability and discover age-associated EV proteins (n=4 with 4 serial freeze-thaws each); validation by high-resolution flow cytometry and EV cytokine quantification by multiplex ELISA (n=28 healthy donors, aged 18-83 years); quantification of WI-38 fibroblast cell proliferation response to co-culture with PKH67-labeled young and old plasma EVs. The EV samples from these plasma specimens were previously characterized for bilayer structure, intra-vesicle mitochondria and cytokines, and hematopoietic cell-related surface markers. Results: Compared with matched exo-EVs (EV-depleted supernatants), endo-EVs (EV-associated) had higher mean TNF-α and IL-27, lower mean IL-6, IL-11, IFN-γ, and IL-17A/F, and similar mean IL-1β, IL-21, and IL-22 concentrations. Some endo-EV and exo-EV cytokine concentrations were correlated, including TNF-α, IL-27, IL-6, IL-1β, and IFN-γ, but not IL-11, IL-17A/F, IL-21 or IL-22. Endo-EV IFN-γ and exo-EV IL-17A/F and IL-21 declined with age. By proteomics and confirmed by flow cytometry, we identified age-associated decline of fibrinogen (FGA, FGB and FGG) in EVs. Age-related EV proteins indicated predominant origins in the liver and innate immune system. WI-38 cells (>95%) internalized similar amounts of young and old plasma EVs, but cells that internalized PKH67-EVs, particularly young EVs, underwent significantly greater cell proliferation. Conclusion: Endo-EV and exo-EV cytokines function as different biomarkers. The observed healthy aging EV phenotype reflected a downregulation of EV fibrinogen subpopulations consistent with the absence of a pro-coagulant and pro-inflammatory condition common with age-related disease.

Indexed as

Extracellular VesiclesHealthy AgingInterleukin-27AdultCytokinesFibrinogenHumansImmune SystemInterleukin-17Interleukin-6Organic ChemicalsTumor Necrosis Factor-alphaCytokinesFibrinogenInterleukin-17Interleukin-27Interleukin-6Organic ChemicalsPKH67Tumor Necrosis Factor-alphacytokinesextracellular vesicleshealthy agingimmune systemproliferationproteomicssurface markers

Identifiers

PMID38633262
PMCPMC11021711
OpenAlexW4393900322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.